HAWKINS INC. 10-Q Summary: Period Ended September 30, 2009
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2009 (the first half of fiscal 2010). Hawkins, Inc. is a distributor of bulk and specialty chemicals operating primarily in the United States. The company reports through two segments: Industrial and Water Treatment. The Pharmaceutical segment was divested in May 2009 and is reported as discontinued operations.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2009 | Six Months Ended Sep 30, 2009 |
|---|---|---|
| Sales | $64,976,000 | $138,562,000 |
| Gross Profit | $17,416,000 (26.8% margin) | $33,272,000 (24.0% margin) |
| Operating Income | $10,848,000 | $20,349,000 |
| Net Income | $6,665,000 | $12,718,000 |
| Earnings Per Share (Diluted) | $0.65 | $1.24 |
| Cash Flow from Operations | N/A | $27,419,000 |
| Cash and Cash Equivalents | $19,947,000 (Sep 30, 2009) | $19,947,000 (Sep 30, 2009) |
| Investments (Available-for-Sale) | $29,942,000 (Total) | $29,942,000 (Total) |
| Total Debt | None reported | None reported |
Material Changes vs. Prior Period
- Sales Decline: Sales decreased 17.2% ($13.5M) for the quarter and 1.7% ($2.5M) for the six-month period compared to the prior year. This was driven by lower selling prices for bulk chemicals (passing on lower commodity costs) and reduced volumes due to lower demand.
- Margin Expansion: Despite lower sales, gross profit margins improved significantly (26.8% vs. 22.1% for the quarter). This was primarily due to a $4.2M LIFO benefit in the quarter (and $7.0M for six months) resulting from declining raw material costs, alongside a shift toward higher-margin specialty products.
- Segment Performance: The Industrial segment saw sales drop 22.9% and operating income fall $2.6M due to lower bulk volumes and selling prices. Conversely, the Water Treatment segment saw operating income rise $2.2M, driven by increased sales of specialty products.
- Working Capital: Operating cash flow surged to $27.4M for the six months (vs. $8.4M prior year) due to a $11.2M reduction in working capital, specifically lower inventory and receivables levels driven by falling commodity prices.
Outlook, Risks, and Management Commentary
- Commodity Price Volatility: Management notes that while raw material costs have declined, selling prices are expected to continue declining, which may reduce reported gross profit dollars in future quarters toward historic levels.
- LIFO Impact: The company utilizes the LIFO inventory method. The significant decrease in the LIFO reserve in the first half of fiscal 2010 artificially boosted reported gross profit. Management expects this benefit to diminish as costs stabilize.
- Capital Expenditures: The company invested approximately $10M in two new facilities (Centralia, IL and Minneapolis, MN) to expand capacity. Capital expenditures for the six months were $4.5M. Management expects cash flows to be sufficient to fund future capex.
- Liquidity: The company holds $19.9M in cash and $29.9M in certificates of deposit. There is no long-term debt. Investments are subject to interest rate risk but are held to maturity.
- Risks: Primary risks include the cyclical nature of commodity chemical prices and the inability to pass cost increases to customers. There are no material pending legal proceedings.
Investor Verification Checklist
- LIFO Reserve Sensitivity: Verify the sustainability of current gross margins given the $7M LIFO benefit; margins may normalize downward as commodity prices stabilize.
- Bulk vs. Specialty Mix: Monitor the shift in revenue mix from bulk chemicals (lower margin, volume-driven) to specialty chemicals (higher margin) to assess long-term profitability trends.
- Working Capital Normalization: Assess if the $11M reduction in working capital is a one-time benefit of falling prices or a structural change in inventory management.
- Investment Portfolio: Review the $30M in certificates of deposit for any potential impairment risks if interest rates rise significantly, though management intends to hold to recovery.